Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Neoplasms | 65 | 2024 | 9182 | 5.160 |
Why?
|
Glioma | 35 | 2024 | 3523 | 4.290 |
Why?
|
Glioblastoma | 27 | 2024 | 3523 | 2.970 |
Why?
|
Meningeal Neoplasms | 12 | 2024 | 1251 | 2.070 |
Why?
|
Meningioma | 10 | 2024 | 1222 | 2.020 |
Why?
|
Magnetic Resonance Imaging | 57 | 2024 | 36840 | 1.540 |
Why?
|
Angiogenesis Inhibitors | 9 | 2021 | 2062 | 1.480 |
Why?
|
Isocitrate Dehydrogenase | 12 | 2024 | 954 | 1.340 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2024 | 9425 | 1.020 |
Why?
|
Tumor Burden | 9 | 2023 | 1909 | 0.920 |
Why?
|
Artificial Intelligence | 9 | 2024 | 2659 | 0.740 |
Why?
|
Glutarates | 2 | 2020 | 243 | 0.690 |
Why?
|
Central Nervous System Neoplasms | 3 | 2021 | 928 | 0.610 |
Why?
|
Image Interpretation, Computer-Assisted | 8 | 2024 | 3408 | 0.550 |
Why?
|
Cranial Irradiation | 1 | 2019 | 395 | 0.530 |
Why?
|
Tyrosine | 1 | 2018 | 1428 | 0.460 |
Why?
|
World Health Organization | 1 | 2019 | 1328 | 0.430 |
Why?
|
Humans | 122 | 2024 | 768451 | 0.420 |
Why?
|
Mutation | 16 | 2024 | 30243 | 0.410 |
Why?
|
Iohexol | 1 | 2013 | 205 | 0.410 |
Why?
|
Tomography, X-Ray Computed | 15 | 2024 | 20762 | 0.410 |
Why?
|
Radiosurgery | 3 | 2020 | 1354 | 0.400 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2020 | 3783 | 0.380 |
Why?
|
Temporal Lobe | 1 | 2019 | 1728 | 0.370 |
Why?
|
Cerebellar Neoplasms | 3 | 2022 | 590 | 0.370 |
Why?
|
Retrospective Studies | 38 | 2023 | 81834 | 0.370 |
Why?
|
Public Health | 1 | 2024 | 2693 | 0.360 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 1680 | 0.350 |
Why?
|
Middle Aged | 50 | 2024 | 223418 | 0.310 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5426 | 0.290 |
Why?
|
Cerebral Angiography | 1 | 2013 | 1282 | 0.290 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2019 | 350 | 0.290 |
Why?
|
Adult | 47 | 2024 | 223542 | 0.280 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1107 | 0.270 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2019 | 1794 | 0.270 |
Why?
|
Diagnostic Imaging | 4 | 2022 | 3543 | 0.270 |
Why?
|
Combined Modality Therapy | 4 | 2020 | 8559 | 0.270 |
Why?
|
Young Adult | 25 | 2024 | 60045 | 0.270 |
Why?
|
Duodenal Diseases | 1 | 2007 | 101 | 0.270 |
Why?
|
Cerebrovascular Disorders | 1 | 2013 | 1487 | 0.260 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2019 | 640 | 0.260 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1226 | 0.260 |
Why?
|
Prognosis | 15 | 2024 | 30028 | 0.260 |
Why?
|
Aged | 38 | 2024 | 171520 | 0.260 |
Why?
|
Medulloblastoma | 2 | 2022 | 682 | 0.260 |
Why?
|
Central Nervous System Diseases | 2 | 2020 | 521 | 0.250 |
Why?
|
Aged, 80 and over | 22 | 2024 | 59680 | 0.250 |
Why?
|
Diverticulum | 1 | 2007 | 137 | 0.250 |
Why?
|
Observer Variation | 4 | 2021 | 2622 | 0.240 |
Why?
|
Intestinal Perforation | 1 | 2007 | 253 | 0.240 |
Why?
|
Male | 50 | 2024 | 364781 | 0.230 |
Why?
|
Female | 52 | 2024 | 396943 | 0.230 |
Why?
|
DNA Repair Enzymes | 2 | 2018 | 347 | 0.230 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 1014 | 0.230 |
Why?
|
Brain | 8 | 2022 | 27438 | 0.220 |
Why?
|
Neurofibromin 2 | 1 | 2024 | 272 | 0.220 |
Why?
|
Receptors, Somatostatin | 1 | 2024 | 138 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 5 | 2023 | 2823 | 0.210 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6657 | 0.210 |
Why?
|
Ovariectomy | 2 | 2003 | 614 | 0.210 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8051 | 0.210 |
Why?
|
Amnesia, Transient Global | 1 | 2022 | 19 | 0.200 |
Why?
|
Disease Progression | 8 | 2019 | 13655 | 0.200 |
Why?
|
Nandrolone | 1 | 2002 | 16 | 0.200 |
Why?
|
Neurosurgical Procedures | 3 | 2024 | 2097 | 0.200 |
Why?
|
Follow-Up Studies | 12 | 2019 | 39430 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7451 | 0.200 |
Why?
|
Lymphoma | 2 | 2022 | 1907 | 0.200 |
Why?
|
Melanoma | 1 | 2020 | 5740 | 0.200 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2022 | 92 | 0.200 |
Why?
|
Lung Neoplasms | 3 | 2021 | 13589 | 0.190 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3197 | 0.180 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2022 | 1427 | 0.180 |
Why?
|
Spinal Cord Neoplasms | 1 | 2023 | 263 | 0.180 |
Why?
|
Optic Nerve | 1 | 2024 | 572 | 0.180 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3550 | 0.170 |
Why?
|
Disease-Free Survival | 5 | 2020 | 6856 | 0.170 |
Why?
|
Discitis | 1 | 2020 | 45 | 0.170 |
Why?
|
Ovarian Cysts | 1 | 2020 | 108 | 0.170 |
Why?
|
Infratentorial Neoplasms | 1 | 2020 | 99 | 0.160 |
Why?
|
Intraoperative Period | 1 | 2020 | 513 | 0.160 |
Why?
|
Anabolic Agents | 1 | 2002 | 256 | 0.160 |
Why?
|
Algorithms | 8 | 2024 | 14158 | 0.160 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4298 | 0.160 |
Why?
|
Dictionaries as Topic | 1 | 2018 | 11 | 0.160 |
Why?
|
Encephalitis | 1 | 2022 | 441 | 0.160 |
Why?
|
Cerebral Veins | 1 | 2019 | 157 | 0.150 |
Why?
|
Whole Body Imaging | 1 | 2020 | 285 | 0.150 |
Why?
|
Medical Oncology | 3 | 2024 | 2347 | 0.150 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13708 | 0.150 |
Why?
|
Hemangioblastoma | 1 | 2018 | 62 | 0.150 |
Why?
|
Reproducibility of Results | 10 | 2024 | 20231 | 0.150 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 556 | 0.150 |
Why?
|
Postoperative Period | 2 | 2020 | 1833 | 0.140 |
Why?
|
Immunotherapy | 4 | 2024 | 4728 | 0.140 |
Why?
|
Survival Rate | 8 | 2019 | 12875 | 0.140 |
Why?
|
Facial Nerve | 1 | 2019 | 277 | 0.140 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 493 | 0.140 |
Why?
|
Contrast Media | 6 | 2020 | 5336 | 0.140 |
Why?
|
Consensus | 6 | 2023 | 3207 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2023 | 9066 | 0.140 |
Why?
|
Glycine | 1 | 2020 | 672 | 0.140 |
Why?
|
Language | 2 | 2019 | 1557 | 0.130 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2003 | 875 | 0.130 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2915 | 0.130 |
Why?
|
Necrosis | 1 | 2020 | 1621 | 0.130 |
Why?
|
Perfusion | 1 | 2021 | 1402 | 0.130 |
Why?
|
Spinal Stenosis | 1 | 2019 | 261 | 0.130 |
Why?
|
Tibia | 1 | 2002 | 1075 | 0.130 |
Why?
|
Survival Analysis | 4 | 2018 | 10125 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 197 | 0.130 |
Why?
|
Treatment Outcome | 9 | 2024 | 65409 | 0.120 |
Why?
|
Nervous System Neoplasms | 1 | 2015 | 91 | 0.120 |
Why?
|
Postoperative Care | 2 | 2019 | 1481 | 0.120 |
Why?
|
Cohort Studies | 8 | 2024 | 41797 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2022 | 2048 | 0.120 |
Why?
|
Chordoma | 1 | 2018 | 350 | 0.120 |
Why?
|
Spine | 2 | 2020 | 1142 | 0.120 |
Why?
|
Skull Base Neoplasms | 1 | 2018 | 281 | 0.120 |
Why?
|
Lumbar Vertebrae | 2 | 2021 | 1885 | 0.120 |
Why?
|
Osteoporosis | 2 | 2003 | 1606 | 0.120 |
Why?
|
Dexamethasone | 1 | 2022 | 1965 | 0.120 |
Why?
|
Neoplasms | 3 | 2024 | 22386 | 0.110 |
Why?
|
ROC Curve | 2 | 2020 | 3624 | 0.110 |
Why?
|
Sarcoidosis | 1 | 2019 | 539 | 0.110 |
Why?
|
Proteomics | 3 | 2005 | 3901 | 0.110 |
Why?
|
Retreatment | 1 | 2015 | 601 | 0.110 |
Why?
|
Prospective Studies | 7 | 2023 | 54914 | 0.110 |
Why?
|
Predictive Value of Tests | 6 | 2021 | 15460 | 0.110 |
Why?
|
Patient Admission | 1 | 2021 | 1370 | 0.110 |
Why?
|
Semantics | 1 | 2017 | 617 | 0.110 |
Why?
|
Chromosome Deletion | 1 | 2018 | 1390 | 0.110 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2896 | 0.110 |
Why?
|
Synchrotrons | 2 | 2003 | 40 | 0.110 |
Why?
|
Spectrophotometry, Infrared | 2 | 2003 | 117 | 0.110 |
Why?
|
Proportional Hazards Models | 5 | 2021 | 12561 | 0.110 |
Why?
|
Gene Fusion | 1 | 2016 | 356 | 0.100 |
Why?
|
Facial Injuries | 1 | 2014 | 191 | 0.100 |
Why?
|
Radiopharmaceuticals | 3 | 2024 | 2731 | 0.100 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 637 | 0.100 |
Why?
|
DNA Modification Methylases | 1 | 2013 | 210 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2018 | 1444 | 0.100 |
Why?
|
Bone Density | 2 | 2003 | 3561 | 0.100 |
Why?
|
Pattern Recognition, Automated | 2 | 2023 | 998 | 0.100 |
Why?
|
Radiotherapy Dosage | 1 | 2019 | 2925 | 0.100 |
Why?
|
Brain Diseases | 1 | 2021 | 1553 | 0.100 |
Why?
|
Area Under Curve | 1 | 2016 | 1640 | 0.100 |
Why?
|
Facial Transplantation | 1 | 2014 | 222 | 0.100 |
Why?
|
Salvage Therapy | 2 | 2018 | 1277 | 0.100 |
Why?
|
Brain Mapping | 3 | 2019 | 6740 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 5342 | 0.090 |
Why?
|
Radiation Injuries | 1 | 2018 | 1205 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1127 | 0.090 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14728 | 0.090 |
Why?
|
Pyridines | 2 | 2020 | 2888 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1638 | 0.090 |
Why?
|
Macaca fascicularis | 2 | 2003 | 903 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 866 | 0.090 |
Why?
|
Adolescent | 10 | 2020 | 89168 | 0.090 |
Why?
|
Image Enhancement | 2 | 2018 | 2894 | 0.080 |
Why?
|
Subtraction Technique | 1 | 2012 | 519 | 0.080 |
Why?
|
Child | 10 | 2024 | 80863 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3123 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11249 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2785 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11843 | 0.070 |
Why?
|
Phenotype | 3 | 2020 | 16712 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2834 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4083 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4266 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3611 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3520 | 0.070 |
Why?
|
Lomustine | 2 | 2017 | 60 | 0.070 |
Why?
|
Structural Homology, Protein | 1 | 2005 | 87 | 0.060 |
Why?
|
Incidence | 2 | 2021 | 21552 | 0.060 |
Why?
|
Metalloproteins | 1 | 2005 | 98 | 0.060 |
Why?
|
Edema | 2 | 2023 | 766 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4077 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2016 | 2987 | 0.060 |
Why?
|
Genomics | 4 | 2024 | 5909 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 13026 | 0.060 |
Why?
|
Carbonates | 1 | 2003 | 21 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6537 | 0.060 |
Why?
|
Preoperative Care | 1 | 2013 | 2257 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4906 | 0.050 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2003 | 162 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3665 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2819 | 0.050 |
Why?
|
Quality Improvement | 1 | 2018 | 3858 | 0.050 |
Why?
|
Isotope Labeling | 1 | 2024 | 395 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10358 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2017 | 3735 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2024 | 3734 | 0.050 |
Why?
|
Genotype | 1 | 2016 | 13047 | 0.050 |
Why?
|
Solubility | 1 | 2003 | 1086 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 506 | 0.050 |
Why?
|
Diffusion | 1 | 2023 | 818 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2019 | 22293 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 263 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 249 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1734 | 0.050 |
Why?
|
Nuclear Medicine | 1 | 2024 | 259 | 0.050 |
Why?
|
Animals | 8 | 2023 | 169418 | 0.040 |
Why?
|
Propensity Score | 2 | 2019 | 1971 | 0.040 |
Why?
|
Nerve Net | 1 | 2013 | 2362 | 0.040 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2003 | 399 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 631 | 0.040 |
Why?
|
Child, Preschool | 5 | 2020 | 42623 | 0.040 |
Why?
|
Bone Remodeling | 1 | 2003 | 583 | 0.040 |
Why?
|
Philadelphia | 1 | 2020 | 271 | 0.040 |
Why?
|
Rhode Island | 1 | 2020 | 353 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4421 | 0.040 |
Why?
|
Benzamides | 1 | 2024 | 1381 | 0.040 |
Why?
|
Pyrazines | 1 | 2024 | 1206 | 0.040 |
Why?
|
DNA Helicases | 1 | 2024 | 853 | 0.040 |
Why?
|
United States | 2 | 2024 | 73121 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2019 | 528 | 0.040 |
Why?
|
Electric Power Supplies | 1 | 2018 | 96 | 0.040 |
Why?
|
Software | 1 | 2012 | 4463 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2023 | 783 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 1103 | 0.040 |
Why?
|
Cranial Fossa, Posterior | 1 | 2018 | 134 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
Ligands | 1 | 2024 | 3281 | 0.040 |
Why?
|
Rare Diseases | 1 | 2022 | 630 | 0.030 |
Why?
|
Benchmarking | 1 | 2024 | 1058 | 0.030 |
Why?
|
Automation | 1 | 2019 | 588 | 0.030 |
Why?
|
Neuroendoscopy | 1 | 2018 | 101 | 0.030 |
Why?
|
Negotiating | 1 | 2018 | 152 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 433 | 0.030 |
Why?
|
Caenorhabditis elegans | 2 | 2003 | 1462 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2640 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 876 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 618 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1230 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2018 | 386 | 0.030 |
Why?
|
Bone and Bones | 2 | 2003 | 2589 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1924 | 0.030 |
Why?
|
Proteome | 2 | 2003 | 1881 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12096 | 0.030 |
Why?
|
Preoperative Period | 1 | 2017 | 564 | 0.030 |
Why?
|
Collagen | 1 | 2003 | 2646 | 0.030 |
Why?
|
Gadolinium | 1 | 2020 | 965 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1531 | 0.030 |
Why?
|
Meglumine | 1 | 2015 | 144 | 0.030 |
Why?
|
Genome | 1 | 2003 | 1749 | 0.030 |
Why?
|
Sulfonamides | 1 | 2024 | 1988 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2018 | 794 | 0.030 |
Why?
|
Radiology Information Systems | 1 | 2019 | 533 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1348 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 474 | 0.030 |
Why?
|
Carmustine | 1 | 2014 | 137 | 0.030 |
Why?
|
Information Dissemination | 1 | 2022 | 1138 | 0.030 |
Why?
|
Anilides | 1 | 2017 | 415 | 0.030 |
Why?
|
China | 1 | 2020 | 2398 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 665 | 0.030 |
Why?
|
Gene Expression | 2 | 2003 | 7605 | 0.030 |
Why?
|
Craniotomy | 1 | 2018 | 748 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1320 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2021 | 6400 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3615 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3463 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2358 | 0.030 |
Why?
|
Histones | 1 | 2023 | 2595 | 0.030 |
Why?
|
Software Validation | 1 | 2012 | 59 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2018 | 3438 | 0.020 |
Why?
|
Functional Laterality | 1 | 2019 | 2268 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2015 | 649 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3619 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3472 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4368 | 0.020 |
Why?
|
Neurosurgery | 1 | 2018 | 690 | 0.020 |
Why?
|
Escherichia coli | 1 | 2003 | 4220 | 0.020 |
Why?
|
Seizures | 1 | 2024 | 2996 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1376 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6135 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 1669 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2930 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3939 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5808 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4642 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2103 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2020 | 4780 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8635 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2162 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10784 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2013 | 1749 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36497 | 0.020 |
Why?
|
Rest | 1 | 2013 | 952 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18478 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4931 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2525 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6008 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4453 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6816 | 0.020 |
Why?
|
Massachusetts | 1 | 2018 | 8908 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9263 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2005 | 143 | 0.020 |
Why?
|
Decision Making | 1 | 2018 | 3961 | 0.010 |
Why?
|
Sequence Analysis, Protein | 1 | 2005 | 265 | 0.010 |
Why?
|
Mice | 2 | 2023 | 82045 | 0.010 |
Why?
|
Transcription Factors | 1 | 2024 | 12174 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18388 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6091 | 0.010 |
Why?
|
Models, Molecular | 2 | 2005 | 5443 | 0.010 |
Why?
|
DNA, Helminth | 1 | 2003 | 35 | 0.010 |
Why?
|
Databases, Protein | 1 | 2005 | 387 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14766 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 250 | 0.010 |
Why?
|
Genes, Helminth | 1 | 2003 | 146 | 0.010 |
Why?
|
Purine Nucleosides | 1 | 2002 | 30 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26351 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11674 | 0.010 |
Why?
|
Helminth Proteins | 1 | 2003 | 172 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8081 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11138 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5803 | 0.010 |
Why?
|
Gene Order | 1 | 2002 | 169 | 0.010 |
Why?
|
Computational Biology | 2 | 2005 | 3546 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5308 | 0.010 |
Why?
|
X-Ray Diffraction | 1 | 2002 | 418 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10090 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2005 | 1987 | 0.010 |
Why?
|
Introns | 1 | 2003 | 970 | 0.010 |
Why?
|
Databases as Topic | 1 | 2002 | 475 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2005 | 3073 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2003 | 812 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26395 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2003 | 1992 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24311 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2003 | 1094 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2751 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4175 | 0.010 |
Why?
|
Exons | 1 | 2003 | 2392 | 0.010 |
Why?
|
Binding Sites | 1 | 2005 | 6030 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1750 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2237 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3790 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18048 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74915 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2002 | 1897 | 0.010 |
Why?
|
Protein Binding | 1 | 2005 | 9376 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15880 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13452 | 0.010 |
Why?
|
Hippocampus | 1 | 2002 | 3783 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17647 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2002 | 3861 | 0.000 |
Why?
|
Epilepsy | 1 | 2002 | 3324 | 0.000 |
Why?
|